Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06339008
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2024-03-25
Brief Title:
A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis PREPARED-1
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Perennial Allergic Rhinitis PAR |
Keywords: